Target validation studies confirm expression of therapeutic targets and demonstrate on-target drug engagement in PDX models. We utilize IHC on pelleted PDX-derived cells and flow cytometry to verify target protein expression, assess drug-target binding, and evaluate downstream signaling pathway modulation.